Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2339-59-5

Post Buying Request

2339-59-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2339-59-5 Usage

Description

4-FLUORO-BENZAMIDINE HCL H2O, also known as 4-Fluorobenzamidine, Hydrochloride, Monohydrate (CAS# 2339-59-5), is a white crystalline solid compound that is primarily used in organic synthesis. It is characterized by its unique chemical structure, which makes it a valuable component in the creation of various chemical compounds and materials.

Uses

Used in Organic Synthesis:
4-FLUORO-BENZAMIDINE HCL H2O is used as a synthetic building block for the development of new organic compounds. Its application in this field is due to its versatile chemical properties, which allow it to be easily integrated into a wide range of chemical reactions and processes.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-FLUORO-BENZAMIDINE HCL H2O is used as an intermediate in the synthesis of various drugs and drug candidates. Its unique chemical structure contributes to the development of new therapeutic agents with potential applications in treating various diseases and medical conditions.
Used in Chemical Research:
4-FLUORO-BENZAMIDINE HCL H2O is also utilized in chemical research as a tool to study and understand the properties and behavior of different chemical compounds. Its use in this context is driven by its ability to interact with a variety of other molecules, providing valuable insights into chemical reactions and mechanisms.
Used in Material Science:
In the field of material science, 4-FLUORO-BENZAMIDINE HCL H2O is employed in the development of new materials with specific properties. Its incorporation into various materials can result in improved performance characteristics, such as enhanced stability, reactivity, or selectivity, depending on the desired application.

Check Digit Verification of cas no

The CAS Registry Mumber 2339-59-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,3,3 and 9 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2339-59:
(6*2)+(5*3)+(4*3)+(3*9)+(2*5)+(1*9)=85
85 % 10 = 5
So 2339-59-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H7FN2.ClH.H2O/c8-6-3-1-5(2-4-6)7(9)10;;/h1-4H,(H3,9,10);1H;1H2

2339-59-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Fluorobenzamidine hydrochloride

1.2 Other means of identification

Product number -
Other names 4-Fluorobenzamidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2339-59-5 SDS

2339-59-5Relevant articles and documents

Novel Allosteric Inhibitors of Deoxyhypusine Synthase against Malignant Melanoma: Design, Synthesis, and Biological Evaluation

Li, Shuai,Li, Xin-Yang,Li, Yu-Heng,Lin, Qi-Qi,Liu, Kai-Li,Meng, Fan-Hao,Qian, Xin-Hua,Wang, De-Pu,Xue, Wen-Han

, p. 13356 - 13372 (2021/09/20)

Based on the novel allosteric site of deoxyhypusine synthase (DHPS), two series of 30 novel 5-(2-methoxyphenoxy)-2-phenylpyrimidin-4-amine derivatives as DHPS inhibitors were designed and synthesized. Among them, compound8m, with the best DHPS inhibitory potency (IC50= 0.014 μM), exhibited excellent inhibition against melanoma cells, which was superior to that of GC7. Besides, molecular docking and molecular dynamics (MD) simulations further proved that compound8mwas tightly bound to the allosteric site of DHPS. Flow cytometric analysis and enzyme-linked immunosorbent assay (ELISA) showed that compound8mcould inhibit the intracellular reactive oxygen species (ROS) level. Furthermore, by western blot analysis, compound8meffectively activated caspase 3 and decreased the expressions of GP-100, tyrosinase, eIF5A2, MMP2, and MMP9. Moreover, both Transwell analysis and wound healing analysis showed that compound8mcould inhibit the invasion and migration of melanoma cells. In thein vivostudy, the tumor xenograft model showed that compound8meffectively inhibited melanoma development with low toxicity.

Discovery of BR102375, a new class of non-TZD PPARγ full agonist for the treatment of type 2 diabetes

Choung, Wonken,Yang, Deokmo,Kim,Choi, Hyukjoon,Lee, Bo Ram,Park, Min,Jang, Su Min,Lim, Jae Soo,Kim, Woo Sik,Kim, Kyung-Hee,Chin, Jungwook,Jung, Kyungjin,Lee, Geumwoo,Hong,Jang, Tae-ho,Joo, Jeongmin,Hwang, Hayoung,Myung, Jayhyuk,Kim, Seong Heon

, p. 2275 - 2282 (2019/06/27)

As a potential treatment of type 2 diabetes, a novel PPARγ non-TZD full agonist, compound 18 (BR102375) was identified from the original lead BR101549 by the SAR efforts of the labile metabolite control through bioisosteres approach. In vitro assessments

NOVEL COMPOUNDS

-

Paragraph 0467; 0468, (2013/06/27)

This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2339-59-5